Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Gene Therapy, RNA-based Therapies), Service,...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "North America, Europe & Asia-Pacific Gene Therapy Cell Culture Media Market Forecast to 2033" report has been added to ResearchAndMarkets.com's...
-
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
-
Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15...
-
Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Market" has been added to ResearchAndMarkets.com's offering. The gene therapy market is forecasted to expand significantly, with a...
-
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Partnership for Cardiac RNA Therapies
-
Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Adeno Associated Virus Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering.The Twice-Monthly Publication Cell and Gene Therapy...
-
MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously...
-
Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...